Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 3NIH 2NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Urinary Bladder Neoplasms 18Pancreatic Neoplasms 17Lung Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Biliary Tract Neoplasms 10Urethral Neoplasms 9Lymphoma 8Uterine Cervical Neoplasms 6Ovarian Neoplasms 6Gallbladder Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Large-Cell, Anaplastic 4Hodgkin Disease 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms 4Sarcoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Bile Duct Neoplasms 3Salivary Gland Neoplasms 2Recurrent Uterine Corpus Sarcoma 2Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Lymphoma, Non-Hodgkin 2Immunoblastic Lymphadenopathy 2Fallopian Tube Neoplasms 2Adenocarcinoma of Lung 2

Interventions

Vincristine 2Prednisone 2Gemcitabine 2Cyclophosphamide 2liposomal amphotericin B 1ixabepilone 1imetelstat 1Watchful Waiting 1VAP-cyclo protocol 1Rituximab 1Radiotherapy 1Palliative Care 1Nutritional Support 1Nicotine 1Moxifloxacin 1Morphine 1Lapatinib 1Everolimus 1Doxorubicin 1Dextromethorphan 1Dexamethasone 1Cytarabine 1Cyclosporins 1Cyclosporine 1Cisplatin 1Ciprofloxacin 1Celecoxib 1Caspofungin 1Analgesia 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Immunoblastic Lymphadenopathy × Gemcitabine × Clear all
NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00079261 2012-09-24

Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
25 enrolled
Lymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡